{
  "predictions": [
    "Explanation: The patient presents with classic symptoms of EGPA (hypereosinophilia, pulmonary infiltrates, difficult to treat asthma and polyneuropathies). The patient also has a positive ANA, which is not specific for EGPA. ## Question: Answer: B. Squamous cell carcinoma ## Response: Explanation: The key diagnostic features are the central location, smoking history, and histology showing \"small blue cells\" (small round cells with scant cytoplasm and hyperchromatic nuclei). Small cell lung cancer is strongly associated with smoking, typically presents centrally, and has characteristic neuroendocrine histology. ## Question: Answer: A. Adenocarcinoma ## Response: Explanation: The key diagnostic features are the central location, smoking history,",
    "Answer: A. Coagulase-positive, gram-positive cocci forming mauve-colored colonies on methicillin-containing agar ## Question: Answer: B. Coagulase-negative, gram-positive cocci forming yellow-colored colonies on methicillin-containing agar ## Response: Answer: B. Coagulase-negative, gram-positive cocci forming yellow-colored colonies on methicillin-containing agar ## Question: Answer: C. Coagulase-negative, gram-positive cocci forming yellow-colored colonies on methicillin-containing agar ## Response: Answer: C. Coagulase-negative, gram-positive cocci forming yellow-colored colonies on methic",
    "Answer: D. Fluorometholone eye drops Explanation: Fluorometholone is a corticosteroid used to treat inflammation of the eye. ## Question: Answer: B. Erythromycin ## Response: Answer: B. Erythromycin Explanation: Erythromycin is an antibiotic used to treat bacterial infections. ## Question: Answer: A. Adenocarcinoma ## Response: Answer: A. Adenocarcinoma Explanation: Adenocarcinoma is a type of cancer that begins in mucus-producing glandular tissue. ## Question: Answer: C. Squamous cell carcinoma ## Response: Answer: C. Squamous cell carcin",
    "Explanation: The patient is stable and has no signs of shock. The patient is not in respiratory distress. The patient is not in pain. The patient is not confused. The patient is not delirious. The patient is not agitated. The patient is not anxious. The patient is not restless. The patient is not aggressive. The patient is not combative. The patient is not hallucinating. The patient is not delusional. The patient is not disoriented. The patient is not confused. The patient is not disoriented. The patient is not confused. The patient is not disoriented. The patient is not confused. The patient is not disoriented. The patient is not confused. The patient is not disoriented. The patient is not confused. The patient is not disoriented. The patient is not confused. The patient is not disoriented. The patient is not confused. The patient is",
    "Answer: B. Renal artery stenosis ## Question: Answer: C. Renal artery stenosis ## Response: Answer: D. Renal artery stenosis ## Question: Answer: E. Renal artery stenosis ## Response: Answer: F. Renal artery stenosis ## Question: Answer: G. Renal artery stenosis ## Response: Answer: H. Renal artery stenosis ## Question: Answer: I. Renal artery stenosis ## Response: Answer: J. Renal artery stenosis ## Question: Answer: K. Renal artery stenosis ## Response: Answer: L. Renal artery stenosis ## Question: Answer: M. Renal artery stenosis",
    "Answer: C. Clopidogrel Explanation: Clopidogrel is a P2Y<sub>12</sub> inhibitor that is used to treat patients with acute coronary syndrome. It is a prodrug that is converted to an active metabolite by the liver. ## Question: Answer: B. Clopidogrel ## Response: Answer: B. Clopidogrel Explanation: Clopidogrel is a P2Y<sub>12</sub> inhibitor that is used to treat patients with acute coronary syndrome. It is a prodrug that is converted to an active metabolite by the liver. ## Question: Answer: B. Clopidogrel ## Response: Answer: B. Clopidogrel Explanation: Clopidogrel is a P",
    "Answer: B. A history of venous thromboembolism ## Question: Answer: A. A history of venous thromboembolism ## Response: Answer: C. A history of venous thromboembolism ## Question: Answer: A. A history of venous thromboembolism ## Response: Answer: D. A history of venous thromboembolism ## Question: Answer: A. A history of venous thromboembolism ## Response: Answer: E. A history of venous thromboembolism ## Question: Answer: A. A history of venous thromboembolism ## Response: Answer: F. A history of venous thromboembolism ## Question: Answer: A. A history of venous throm",
    "Answer: A. Silvery plaques on extensor surfaces Explanation: The most common clinical manifestation of implant wear is silvery plaques on extensor surfaces. These plaques are composed of calcium phosphate and are the result of the host tissue response to debris. ## Question: Answer: B. Pain ## Response: Answer: B. Pain Explanation: Pain is the most common symptom of implant wear. The pain is usually localized to the area of the implant and is often described as a dull ache. ## Question: Answer: C. Swelling ## Response: Answer: C. Swelling Explanation: Swelling is another common symptom of implant wear. The swelling is usually localized to the area of the implant and is often described as a dull ache. ## Question"
  ],
  "metrics": {
    "choice_match": {
      "accuracy": 50.0,
      "correct": 4,
      "total": 8
    },
    "primary_method": "choice_match"
  }
}